Delivery Order SPE2DB24D2011-SPE2DB25FBRHP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a $37,895.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used anticoagulant medication prescribed for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order valued at $6,889.44 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count package), with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $12,612.95. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a $24,039.10 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement with an ultimate completion date of July 31, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,257.64 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant...
- The Defense Logistics Agency awarded a $7,980.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied from the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,896.80 for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce stroke risk and treat blood clots, reflecting the Defense Logistics Agency...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRHPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $49,762.80 to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count units) on July 18, 2025, with completion expected by July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ELIQUIS is a widely-used anticoagulant medication for stroke prevention and thromboembolism treatment, indicating this procurement supports federal healthcare needs within the military or veteran healthcare system. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, providing brand-name and generic medications, vaccines, and medical supplies to support military operations and healthcare programs globally. The company's substantial IDC vehicle underscores its role as a prime vendor for federal pharmaceutical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.8k | 7/18/25 |